biotech · Post Traumatic Stress Disorder · Prosthetic Joint Infection · ADPT
Adaptive Biotechnologies
Adaptive Biotechnologies Corp
Adaptive Biotechnologies clinical programs — 19 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1165 Eastlake Ave E, Seattle, Washington 98109, US
- Founded
- 2009
- Employees
- 659
- Programs
- 19
- Drugs
- 23
- Patents
- 12
Adaptive Biotechnologies projects
19 ClinicalTrials.gov programs sponsored by Adaptive Biotechnologies.
Adaptive Biotechnologies has 19 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Ceftriaxone
Adaptive Biotechnologies Corp
Community-acquired Pneumonia, Influenza, COVID-19
1 trial -
GCAR-7213
Adaptive Biotechnologies Corp
Oncology - Glioblastoma (GBM)
1 trial -
Temozolomide
Adaptive Biotechnologies Corp
Glioblastoma
1 trial -
Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset
Adaptive Biotechnologies Corp
Chronic Tonal Tinnitus
1 trial -
Bacteriophage
Adaptive Biotechnologies Corp
Prosthetic Joint Infection
1 trial -
Bacteriophage Therapy
Adaptive Biotechnologies Corp
Urinary Tract Infection Bacterial
1 trial -
Bacteriophage Therapy
Adaptive Biotechnologies Corp
Osteomyelitis
1 trial -
Bendamustine
Adaptive Biotechnologies Corp
Lymphoma
1 trial -
Intervention A Fluoxetine Hydrochloride (HCl)
Adaptive Biotechnologies Corp
Post Traumatic Stress Disorder
2 trials -
Intervention B Vilazodone Hydrochloride (HCl)
Adaptive Biotechnologies Corp
Post Traumatic Stress Disorder
1 trial -
Intervention C Daridorexant
Adaptive Biotechnologies Corp
Post Traumatic Stress Disorder
1 trial -
Intervention D SLS-002
Adaptive Biotechnologies Corp
Post Traumatic Stress Disorder
1 trial -
Mosunetuzumab
Adaptive Biotechnologies Corp
Diffuse Large B-Cell Lymphoma (DLBCL)
1 trial -
Nivolumab
Adaptive Biotechnologies Corp
Bladder Cancer
1 trial -
Obinutuzumab
Adaptive Biotechnologies Corp
Mantle Cell Lymphoma
1 trial -
Phage Therapy
Adaptive Biotechnologies Corp
Prosthetic Joint Infection
2 trials -
Venetoclax monotherapy
Adaptive Biotechnologies Corp
Chronic Lymphocytic Leukemia (CLL)
1 trial -
ANM T30 CR®-System
Adaptive Biotechnologies Corp
Tinnitus
1 trial -
Radiation
Adaptive Biotechnologies Corp
Rectal Cancer
1 trial
Frequently asked questions
How many clinical projects does Adaptive Biotechnologies have?
19 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.